Turchi, L.; Sakakini, N.; Saviane, G.; Polo, B.; Saurty-Seerunghen, M.S.; Gabut, M.; Gouillou, C.A.; Guerlais, V.; Pasquier, C.; Vignais, M.L.;
et al. Correction: Turchi et al. CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3. Cancers 2023, 15, 5038. Cancers 2025, 17, 1583.
https://doi.org/10.3390/cancers17091583
AMA Style
Turchi L, Sakakini N, Saviane G, Polo B, Saurty-Seerunghen MS, Gabut M, Gouillou CA, Guerlais V, Pasquier C, Vignais ML,
et al. Correction: Turchi et al. CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3. Cancers 2023, 15, 5038. Cancers. 2025; 17(9):1583.
https://doi.org/10.3390/cancers17091583
Chicago/Turabian Style
Turchi, Laurent, Nathalie Sakakini, Gaelle Saviane, Béatrice Polo, Mirca Saras Saurty-Seerunghen, Mathieu Gabut, Corine Auge Gouillou, Vincent Guerlais, Claude Pasquier, Marie Luce Vignais,
and et al. 2025. "Correction: Turchi et al. CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3. Cancers 2023, 15, 5038" Cancers 17, no. 9: 1583.
https://doi.org/10.3390/cancers17091583
APA Style
Turchi, L., Sakakini, N., Saviane, G., Polo, B., Saurty-Seerunghen, M. S., Gabut, M., Gouillou, C. A., Guerlais, V., Pasquier, C., Vignais, M. L., Almairac, F., Chneiweiss, H., Junier, M.-P., Burel-Vandenbos, F., & Virolle, T.
(2025). Correction: Turchi et al. CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3. Cancers 2023, 15, 5038. Cancers, 17(9), 1583.
https://doi.org/10.3390/cancers17091583
